JP4698773B2 - 新規な脂肪酸誘導体 - Google Patents
新規な脂肪酸誘導体 Download PDFInfo
- Publication number
- JP4698773B2 JP4698773B2 JP53186398A JP53186398A JP4698773B2 JP 4698773 B2 JP4698773 B2 JP 4698773B2 JP 53186398 A JP53186398 A JP 53186398A JP 53186398 A JP53186398 A JP 53186398A JP 4698773 B2 JP4698773 B2 JP 4698773B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- acid
- arh
- cis
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 0 C*c1ccc(*N)cc1 Chemical compound C*c1ccc(*N)cc1 0.000 description 7
- NJESAXZANHETJV-UHFFFAOYSA-N Cc1ccc(C(O)=O)c(O)c1 Chemical compound Cc1ccc(C(O)=O)c(O)c1 NJESAXZANHETJV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
- C07C69/72—Acetoacetic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/88—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9701441.9 | 1997-01-24 | ||
GB9701441A GB2321455A (en) | 1997-01-24 | 1997-01-24 | Lipophilic derivatives of biologically active compounds |
PCT/NO1998/000021 WO1998032718A1 (fr) | 1997-01-24 | 1998-01-23 | Nouveaux derives d'acide gras |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009141714A Division JP5232083B2 (ja) | 1997-01-24 | 2009-06-12 | 新規な脂肪酸誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001522351A JP2001522351A (ja) | 2001-11-13 |
JP4698773B2 true JP4698773B2 (ja) | 2011-06-08 |
Family
ID=10806515
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53186398A Expired - Lifetime JP4698773B2 (ja) | 1997-01-24 | 1998-01-23 | 新規な脂肪酸誘導体 |
JP2009141714A Expired - Lifetime JP5232083B2 (ja) | 1997-01-24 | 2009-06-12 | 新規な脂肪酸誘導体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009141714A Expired - Lifetime JP5232083B2 (ja) | 1997-01-24 | 2009-06-12 | 新規な脂肪酸誘導体 |
Country Status (23)
Country | Link |
---|---|
US (3) | US20010006962A1 (fr) |
EP (1) | EP0977725B1 (fr) |
JP (2) | JP4698773B2 (fr) |
KR (1) | KR100546457B1 (fr) |
AT (1) | ATE269292T1 (fr) |
AU (1) | AU733370B2 (fr) |
CA (1) | CA2276694C (fr) |
CZ (1) | CZ299815B6 (fr) |
DE (1) | DE69824574T2 (fr) |
DK (1) | DK0977725T3 (fr) |
ES (1) | ES2224356T3 (fr) |
GB (1) | GB2321455A (fr) |
HU (1) | HU225664B1 (fr) |
IL (1) | IL130853A (fr) |
NO (1) | NO325518B1 (fr) |
NZ (1) | NZ336724A (fr) |
PL (1) | PL196831B1 (fr) |
RU (1) | RU2227794C2 (fr) |
SK (1) | SK284803B6 (fr) |
TW (1) | TWI231209B (fr) |
UA (1) | UA65557C2 (fr) |
WO (1) | WO1998032718A1 (fr) |
ZA (1) | ZA98579B (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US6207700B1 (en) * | 1999-01-07 | 2001-03-27 | Vanderbilt University | Amide derivatives for antiangiogenic and/or antitumorigenic use |
US7235583B1 (en) * | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
JP4634694B2 (ja) * | 2001-03-23 | 2011-02-16 | ルイトポルド・ファーマシューティカルズ・インコーポレーテッド | 脂肪アルコール薬物複合体 |
US8552054B2 (en) * | 2001-03-23 | 2013-10-08 | Luitpold Pharmaceuticals, Inc. | Fatty amine drug conjugates |
PL374731A1 (en) * | 2002-07-08 | 2005-10-31 | Pliva-Istrazivacki Institut D.O.O. | New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
RS20050006A (en) * | 2002-07-08 | 2007-09-21 | Glaxo Smith Kline Istraživački Centar Zagreb D.O.O., | Novel compounds,compositions as carriers for steroid/non- steroid anti-inflammatory,antineoplastic and antiviral active molecules |
AU2003255849A1 (en) * | 2002-07-08 | 2004-01-23 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
WO2004033478A2 (fr) | 2002-10-08 | 2004-04-22 | Sepracor Inc. | Formes modifiees par l'acide gras des glucocorticoides |
US7196082B2 (en) * | 2002-11-08 | 2007-03-27 | Merck & Co. Inc. | Ophthalmic compositions for treating ocular hypertension |
GB0304927D0 (en) | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
JP2007534702A (ja) | 2004-04-26 | 2007-11-29 | バンダービルト・ユニバーシティ | 胃腸毒性の低い治療薬としてのインドール酢酸、及びインデン酢酸誘導体 |
NO324263B1 (no) | 2005-12-08 | 2007-09-17 | Clavis Pharma Asa | Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser |
US8497292B2 (en) * | 2005-12-28 | 2013-07-30 | Translational Therapeutics, Inc. | Translational dysfunction based therapeutics |
EP2040699A4 (fr) | 2006-06-19 | 2013-03-13 | Vanderbilt University Medical Ct | Méthodes et compositions de diagnostic et de ciblage thérapeutique de cox-2 |
NO331891B1 (no) * | 2007-03-20 | 2012-04-30 | Clavis Pharma Asa | Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS |
RU2488591C2 (ru) * | 2007-09-26 | 2013-07-27 | Маунт Синай Скул Оф Медсин | Аналоги азацитидина и их применение |
WO2010028458A1 (fr) * | 2008-09-12 | 2010-03-18 | Parnell Laboratories (Aust) Pty Ltd | Promédicaments d’isoxazolyl-pénicillines et utilisations de ceux-ci |
JP5805086B2 (ja) * | 2009-08-26 | 2015-11-04 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 抗微生物性アミノサリチル酸誘導体 |
WO2012174121A2 (fr) * | 2011-06-13 | 2012-12-20 | The University Of Kansas | Promédicaments de décoquinate |
WO2013059245A1 (fr) | 2011-10-17 | 2013-04-25 | Vanderbilt University | Analogues de l'indométacine destinés au traitement du cancer de la prostate résistant à la castration |
RU2602810C2 (ru) | 2012-04-27 | 2016-11-20 | Ниппон Дзоки Фармасьютикал Ко., Лтд. | Производное транс-2-деценовой кислоты и содержащее его лекарственное средство |
CN103450141B (zh) * | 2013-08-23 | 2015-08-26 | 山东鲁抗舍里乐药业有限公司 | 一种苯并吡喃酮类化合物、其制备方法及其应用 |
NZ757526A (en) | 2017-04-21 | 2022-02-25 | Univ Tasmania | Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction |
CN111116374B (zh) * | 2019-12-04 | 2020-12-15 | 北京理工大学 | 一种氨鲁米特与2-硝基苯甲酸合成π-π键共晶体的方法 |
JP7231576B2 (ja) | 2020-03-09 | 2023-03-01 | 株式会社日立ハイテク | 電解質濃度測定装置 |
Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2933380A (en) * | 1955-06-22 | 1960-04-19 | Du Pont | Motor fuels |
JPS50129584A (fr) * | 1974-03-25 | 1975-10-13 | ||
GB1581443A (en) * | 1977-04-01 | 1980-12-17 | Mundipharma Ag | Aminosalicylic acid esters |
JPS57131747A (en) * | 1980-12-15 | 1982-08-14 | Fujisawa Pharmaceut Co Ltd | Novel acylpeptide compound, its preparation, and preventive and remedy for microbism containing it as active ingredient |
JPS5982399A (ja) * | 1982-09-30 | 1984-05-12 | メルク・エンド・カムパニ−・インコ−ポレ−テツド | 細胞毒性作用物質を結合させたステロイド化合物の誘導体類 |
JPS60208951A (ja) * | 1984-01-09 | 1985-10-21 | ジ−.デイ.サ−ル アンド コンパニ− | プロテア−ゼ阻害方法および阻害剤 |
JPS6143110A (ja) * | 1984-07-30 | 1986-03-01 | アクチエボラゲツト・ドラコ | ステロイドエステルを含有するリポソーム |
JPS61263969A (ja) * | 1985-05-17 | 1986-11-21 | Takeda Chem Ind Ltd | アスコルビン酸誘導体含有製剤 |
JPS6248657A (ja) * | 1985-06-10 | 1987-03-03 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | 抗炎症活性および鎮痛活性を有する化合物および組成物 |
JPS62258366A (ja) * | 1986-04-28 | 1987-11-10 | ワ−ナ−−ランバ−ト・コンパニ− | 置換ピリミジンアミド |
JPS6348250A (ja) * | 1986-07-30 | 1988-02-29 | ゲデッケ・アクチエンゲゼルシャフト | 2−アシロキシプロピルアミン誘導体、その製造方法、およびそれらを含有する薬学的組成物 |
JPS63295537A (ja) * | 1987-03-09 | 1988-12-01 | ザ、プロクター、エンド、ギャンブル、カンパニー | 新規化合物、医療組成物、及び炎症及び痛みの治療方法 |
JPH0196158A (ja) * | 1987-10-09 | 1989-04-14 | Santen Pharmaceut Co Ltd | 抗炎症剤 |
JPH02212488A (ja) * | 1989-02-13 | 1990-08-23 | Shinichiro Shimizu | トリアゾールピリミジン誘導体 |
JPH0381286A (ja) * | 1989-08-22 | 1991-04-05 | Green Cross Corp:The | ステロイド外用剤 |
JPH04500958A (ja) * | 1988-08-06 | 1992-02-20 | ゲデッケ・アクチェンゲゼルシャフト | アルコキシ―4(1h)―ピリドン誘導体、それらの製造方法およびそれらを含有する医薬組成物 |
JPH04217694A (ja) * | 1990-03-12 | 1992-08-07 | Merck & Co Inc | N−アシル化シクロヘキサペプチド化合物 |
JPH0597839A (ja) * | 1991-04-12 | 1993-04-20 | American Home Prod Corp | ホスホリパーゼa2阻害剤としてのテトロン酸誘導体およびチオテトロン酸誘導体 |
US5462965A (en) * | 1990-08-13 | 1995-10-31 | Gd Searle & Co. | Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases |
JPH08217787A (ja) * | 1995-02-15 | 1996-08-27 | Meiji Seika Kaisha Ltd | 脂溶性アントラサイクリン誘導体 |
JPH08325154A (ja) * | 1995-03-31 | 1996-12-10 | Mitsui Toatsu Chem Inc | 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼa2阻害剤 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1269942A (en) * | 1968-07-25 | 1972-04-06 | Murphy Chemical Ltd | Improvements in or relating to pesticides |
GB1325797A (en) * | 1970-09-24 | 1973-08-08 | Upjohn Co | Medicines comprising cytidine derivatives |
IT1043956B (it) | 1970-10-17 | 1980-02-29 | Isf Spa | 21 esteri di acidi grassi insaturi del desa e beta metazone |
JPS4882023A (fr) * | 1972-02-04 | 1973-11-02 | ||
FR2485001A1 (fr) * | 1980-06-02 | 1981-12-24 | Svatos Antonin | Esters de l'acide ricinoleique et de chloroxylenols et compositions antiparasitaires |
US4554279A (en) * | 1981-01-29 | 1985-11-19 | The United States Of America As Represented By The Secretary Of The Army | 5-(Straight chain 3-12 carbon alkoxy)-8-quinolinamines and their use for treatment of malaria |
JPS61204197A (ja) * | 1985-03-06 | 1986-09-10 | Yoshikawa Seiyu Kk | ステロ−ル脂肪酸エステルの製造方法 |
US5284876A (en) * | 1988-02-26 | 1994-02-08 | Neuromedica, Inc. | Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents |
US5135736A (en) * | 1988-08-15 | 1992-08-04 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
FR2664500B1 (fr) * | 1990-07-13 | 1994-10-28 | Lille Ii Universite Droit Sant | Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant. |
GB2260319B (en) * | 1991-10-07 | 1995-12-06 | Norsk Hydro As | Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity |
US5238933A (en) * | 1991-10-28 | 1993-08-24 | Sri International | Skin permeation enhancer compositions |
WO1993020800A1 (fr) * | 1992-04-08 | 1993-10-28 | Paavo Kai Johannes Kinnunen | Composition a usage therapeutique ou diagnostique, et mode de preparation et d'utilisation |
US5324747A (en) * | 1992-07-15 | 1994-06-28 | Hoffmann-La Roche Inc. | N-substituted anilines, inhibitors of phospholipases A2 |
US5807884A (en) * | 1992-10-30 | 1998-09-15 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
US5466685A (en) * | 1993-05-13 | 1995-11-14 | Johnson & Johnson | Inhibition of expression of beta-lactamase using esters of fatty acid alcohols |
US5952004A (en) * | 1994-03-18 | 1999-09-14 | Shire Laboratories Inc. | Emulsified drug delivery systems |
US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
US5580899A (en) * | 1995-01-09 | 1996-12-03 | The Liposome Company, Inc. | Hydrophobic taxane derivatives |
ATE235505T1 (de) * | 1995-10-30 | 2003-04-15 | Oleoyl Estrone Developments S | Oleat monoester von estrogenen zur behandlung von fettleibigkeit |
-
1997
- 1997-01-24 GB GB9701441A patent/GB2321455A/en not_active Withdrawn
-
1998
- 1998-01-23 DK DK98901593T patent/DK0977725T3/da active
- 1998-01-23 UA UA99084762A patent/UA65557C2/uk unknown
- 1998-01-23 AT AT98901593T patent/ATE269292T1/de active
- 1998-01-23 AU AU57828/98A patent/AU733370B2/en not_active Expired
- 1998-01-23 KR KR1019997006548A patent/KR100546457B1/ko not_active IP Right Cessation
- 1998-01-23 JP JP53186398A patent/JP4698773B2/ja not_active Expired - Lifetime
- 1998-01-23 ZA ZA98579A patent/ZA98579B/xx unknown
- 1998-01-23 CA CA002276694A patent/CA2276694C/fr not_active Expired - Lifetime
- 1998-01-23 EP EP98901593A patent/EP0977725B1/fr not_active Expired - Lifetime
- 1998-01-23 IL IL13085398A patent/IL130853A/xx not_active IP Right Cessation
- 1998-01-23 SK SK1003-99A patent/SK284803B6/sk not_active IP Right Cessation
- 1998-01-23 PL PL334919A patent/PL196831B1/pl unknown
- 1998-01-23 US US09/355,111 patent/US20010006962A1/en not_active Abandoned
- 1998-01-23 CZ CZ0247799A patent/CZ299815B6/cs not_active IP Right Cessation
- 1998-01-23 ES ES98901593T patent/ES2224356T3/es not_active Expired - Lifetime
- 1998-01-23 WO PCT/NO1998/000021 patent/WO1998032718A1/fr active IP Right Grant
- 1998-01-23 RU RU99118313/04A patent/RU2227794C2/ru not_active IP Right Cessation
- 1998-01-23 DE DE69824574T patent/DE69824574T2/de not_active Expired - Lifetime
- 1998-01-23 NZ NZ336724A patent/NZ336724A/en not_active IP Right Cessation
- 1998-01-23 HU HU0000937A patent/HU225664B1/hu not_active IP Right Cessation
- 1998-03-13 TW TW087103693A patent/TWI231209B/zh not_active IP Right Cessation
-
1999
- 1999-07-21 NO NO19993563A patent/NO325518B1/no not_active IP Right Cessation
-
2002
- 2002-04-05 US US10/116,358 patent/US6762175B2/en not_active Expired - Lifetime
-
2003
- 2003-09-16 US US10/662,441 patent/US20040063677A1/en not_active Abandoned
-
2009
- 2009-06-12 JP JP2009141714A patent/JP5232083B2/ja not_active Expired - Lifetime
Patent Citations (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2933380A (en) * | 1955-06-22 | 1960-04-19 | Du Pont | Motor fuels |
JPS50129584A (fr) * | 1974-03-25 | 1975-10-13 | ||
GB1581443A (en) * | 1977-04-01 | 1980-12-17 | Mundipharma Ag | Aminosalicylic acid esters |
JPS57131747A (en) * | 1980-12-15 | 1982-08-14 | Fujisawa Pharmaceut Co Ltd | Novel acylpeptide compound, its preparation, and preventive and remedy for microbism containing it as active ingredient |
JPS5982399A (ja) * | 1982-09-30 | 1984-05-12 | メルク・エンド・カムパニ−・インコ−ポレ−テツド | 細胞毒性作用物質を結合させたステロイド化合物の誘導体類 |
JPS60208951A (ja) * | 1984-01-09 | 1985-10-21 | ジ−.デイ.サ−ル アンド コンパニ− | プロテア−ゼ阻害方法および阻害剤 |
JPS6143110A (ja) * | 1984-07-30 | 1986-03-01 | アクチエボラゲツト・ドラコ | ステロイドエステルを含有するリポソーム |
JPS61263969A (ja) * | 1985-05-17 | 1986-11-21 | Takeda Chem Ind Ltd | アスコルビン酸誘導体含有製剤 |
JPS6248657A (ja) * | 1985-06-10 | 1987-03-03 | ザ、プロクタ−、エンド、ギヤンブル、カンパニ− | 抗炎症活性および鎮痛活性を有する化合物および組成物 |
JPS62258366A (ja) * | 1986-04-28 | 1987-11-10 | ワ−ナ−−ランバ−ト・コンパニ− | 置換ピリミジンアミド |
JPS6348250A (ja) * | 1986-07-30 | 1988-02-29 | ゲデッケ・アクチエンゲゼルシャフト | 2−アシロキシプロピルアミン誘導体、その製造方法、およびそれらを含有する薬学的組成物 |
JPS63295537A (ja) * | 1987-03-09 | 1988-12-01 | ザ、プロクター、エンド、ギャンブル、カンパニー | 新規化合物、医療組成物、及び炎症及び痛みの治療方法 |
JPH0196158A (ja) * | 1987-10-09 | 1989-04-14 | Santen Pharmaceut Co Ltd | 抗炎症剤 |
JPH04500958A (ja) * | 1988-08-06 | 1992-02-20 | ゲデッケ・アクチェンゲゼルシャフト | アルコキシ―4(1h)―ピリドン誘導体、それらの製造方法およびそれらを含有する医薬組成物 |
JPH02212488A (ja) * | 1989-02-13 | 1990-08-23 | Shinichiro Shimizu | トリアゾールピリミジン誘導体 |
JPH0381286A (ja) * | 1989-08-22 | 1991-04-05 | Green Cross Corp:The | ステロイド外用剤 |
JPH04217694A (ja) * | 1990-03-12 | 1992-08-07 | Merck & Co Inc | N−アシル化シクロヘキサペプチド化合物 |
US5462965A (en) * | 1990-08-13 | 1995-10-31 | Gd Searle & Co. | Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases |
JPH0597839A (ja) * | 1991-04-12 | 1993-04-20 | American Home Prod Corp | ホスホリパーゼa2阻害剤としてのテトロン酸誘導体およびチオテトロン酸誘導体 |
JPH08217787A (ja) * | 1995-02-15 | 1996-08-27 | Meiji Seika Kaisha Ltd | 脂溶性アントラサイクリン誘導体 |
JPH08325154A (ja) * | 1995-03-31 | 1996-12-10 | Mitsui Toatsu Chem Inc | 安息香酸誘導体およびそれを有効成分として含有するホスホリパーゼa2阻害剤 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5232083B2 (ja) | 新規な脂肪酸誘導体 | |
AU2005228685B2 (en) | Hydrazide-containing CFTR inhibitor compounds and uses thereof | |
EP2061749B1 (fr) | Promédicaments hydrosolubles positivement chargés d'acétaminophène et de composés associés à vitesse de pénétration cutanée très élevée | |
MX2007007228A (es) | Profarmaco de amida de gemcitabina, composiciones y uso del mismo. | |
US20140315834A1 (en) | Compounds and compositions for use in the prevention and treatment of inflammation-related disorders, pain and fever, skin disorders, cancer and precancerous conditions thereof | |
PL208242B1 (pl) | Pochodna 2-azetydynonu, zawierająca ją farmaceutyczna kompozycja i zastosowanie tej pochodnej, oraz farmaceutyczna kompozycja zawierająca kombinację tej pochodnej i zastosowanie takiej kombinacji | |
US9850195B2 (en) | Aspirin derivatives and uses thereof | |
AU2943300A (en) | Novel ligands of nuclear receptors ppar's | |
CA2522980A1 (fr) | Derives de wortmannine solubles dans l'eau | |
TR200101028T2 (tr) | 2,3-Diikameli piridin türevi, bunun hazırlanmasında kullanılan proses, bunu içeren farmasötik terkip ve ara maddesi | |
US20150157733A1 (en) | Polyethylene glycol derivatives of palmitoylethanolamide and analogous acylethanolamides | |
US20080249140A1 (en) | Quaternary 3 -Amido, N-Methylpyridinium Salts as Anti-Inflammatory Agents | |
KR20010083122A (ko) | 신규한 알레르기 질환 치료제 | |
US5859295A (en) | Canavanine analogs and their use as chemotherapeutic agents | |
KR20040051958A (ko) | 폴리에틸렌글리콜 결합 스핑고지질 유도체 | |
JP2000511916A (ja) | ポリオールスクシネートおよびその医薬製剤 | |
WO2012080555A1 (fr) | Éthers d'hydroxytyrosol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050113 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20060501 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071211 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080311 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080428 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080512 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080616 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080611 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090210 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090612 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20090702 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100302 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100524 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100602 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100702 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100713 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100802 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101207 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110106 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110208 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110302 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |